REHOVOT, Israel, May 29, 2019 /PRNewswire/ -- Techsomed, developer of BioTrace™, the world's first image analysis system for predicting post-treatment ablation morphology in real time, has secured ...
MINNEAPOLIS and TEL AVIV, Israel, Oct. 16, 2025 /PRNewswire/ -- Techsomed Ltd., a pioneering medical AI-powered software company specializing in image-guided therapy is pleased to announce a ...
TEL AVIV, Israel, Sept. 22, 2025 /PRNewswire/ -- Techsomed, a leader in AI-Driven Precision for Image-Guided Care, today announces U.S. FDA 510 (k) clearance expanding indications for BioTraceIO360* ...
New Senior Executive to Accelerate U.S. Launch of AI-Powered BioTraceIO™ Software Suite for Image-Guided Ablation Therapy REHOVOT, Israel, Sept. 24, 2024 /PRNewswire/ -- Techsomed Ltd., a pioneering ...
REHOVOT, Israel , Jan. 8, 2024 /PRNewswire/ -- Techsomed Medical Technologies LTD is thrilled to announce that FDA has granted De Novo clearance for its BioTraceIO, a groundbreaking ultrasound-based ...
REHOVOT, Israel, June 26, 2023 /PRNewswire/ -- Techsomed Ltd., the developer of BioTrace, an AI powered software platform for real time ablation zone imaging and treatment precision enhancement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results